Dr. Patrick Scanlon , DO
Internal Medicine โข Methuen, MA
70 East St
Methuen, MA 018444597
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Patrick Scanlon is listed in NPPES under Internal Medicine.
-
NPI assigned on July 9, 2008; this date does not establish years in practice.
-
Published CMS data list 3,547 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 โ Established patient outpatient office visit: 704 service units.
- 94729 โ Test to examine how well the lungs exchange gases: 536 service units.
- 94060 โ Test to measure expiratory airflow and volume changes before and after medication administration: 394 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 24 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 3,834 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) โ 879 prescription fills, including refills.
- Albuterol Sulfate Hfa (Albuterol Sulfate) โ 569 prescription fills, including refills.
- Prednisone โ 295 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 35 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Massachusetts (2024, 3,795 clinicians with data). Median for this group: 524. Middle half: 200 to 1,073.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 888 in 2020 to 3,547 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
70 East St
Methuen, MA 018444597
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 4 distinct group names: Incare Lawrence, Pllc; Incare Llc; Incare Middleton, Pllc and 1 more. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
New York College Of Osteo Medicine Of New York Institute Of Technology
2008
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,421 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $227,791 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $170,323 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
5,044 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,332,843 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $47,890.70 across 127 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $27,824.00 across 9 records.
- Consulting Fee: $13,629.00 across 3 records.
- Travel and Lodging: $3,416.99 across 12 records.
Reporting-company totals (3 largest of 13)
- Sanofi and Genzyme US Companies: $30,655.31 across 24 records.
- Boehringer Ingelheim Pharmaceuticals, Inc.: $15,268.85 across 21 records.
- AstraZeneca Pharmaceuticals LP: $699.84 across 24 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
18 years (graduated 2008)
CMS Doctors and Clinicians data list 2008 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Scanlon has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Scanlon as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Methuen and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Massachusetts (2024, 3,795 clinicians with data). Median for this group: 524. Middle half: 200 to 1,073.
Too few clinicians listed under Internal Medicine in Methuen have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Massachusetts (2024, 3,795 clinicians with data). Median for this group: $50,126. Middle half: $19,685 to $96,485.
Too few clinicians listed under Internal Medicine in Methuen have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Internal Medicine in Massachusetts (2024, 3,795 clinicians with data). Median for this group: $38,152. Middle half: $14,838 to $74,912.
Too few clinicians listed under Internal Medicine in Methuen have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Internal Medicine in Massachusetts (2024, 3,672 clinicians with data). Median for this group: 1,174. Middle half: 129 to 3,740.
Too few clinicians listed under Internal Medicine in Methuen have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Massachusetts (2024, 3,672 clinicians with data). Median for this group: $103,819. Middle half: $9,088 to $319,703.
Too few clinicians listed under Internal Medicine in Methuen have Medicare Part D data for 2024 to compare.
15 active clinicians are listed under Internal Medicine with a practice address in Methuen, MA (6,830 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Methuen
26.7% of these 15 clinicians have the CMS telehealth indicator.
66.7% of these 15 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 299% from 888 in 2020 to 3,547 in 2024.
- 2020: 888
- 2021: 793
- 2022: 2,785
- 2023: 2,469
- 2024: 3,547
-
Medicare-allowed amount
Medicare-allowed amount increased 162% from $87,042 in 2020 to $227,791 in 2024.
- 2020: $87,042
- 2021: $99,577
- 2022: $226,915
- 2023: $177,097
- 2024: $227,791
-
Paid by Medicare
Paid by Medicare increased 162% from $64,935 in 2020 to $170,323 in 2024.
- 2020: $64,935
- 2021: $80,926
- 2022: $178,231
- 2023: $134,751
- 2024: $170,323
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 168% from 1,433 in 2020 to 3,834 in 2024.
- 2020: 1,433
- 2021: 634
- 2022: 1,694
- 2023: 2,858
- 2024: 3,834
-
30-day fills
30-day fills increased 166% from 1,900 in 2020 to 5,044 in 2024.
- 2020: 1,900
- 2021: 806
- 2022: 2,164
- 2023: 3,616
- 2024: 5,044
-
Part D drug cost
Part D drug cost increased 390% from $476,319 in 2020 to $2,332,843 in 2024.
- 2020: $476,319
- 2021: $223,848
- 2022: $819,909
- 2023: $1,297,428
- 2024: $2,332,843
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $767.31 in 2021 to $47,890.70 in 2025.
- 2021: $767.31
- 2022: $4,286.65
- 2023: $9,998.19
- 2024: $8,666.67
- 2025: $47,890.70
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 127 records totaling $47,890.70.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $6,137.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $6,075.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $4,693.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $3,971.00 |
| Sanofi and Genzyme US Companies |
Consulting Fee
Cash or cash equivalent
|
โ | General | $3,804.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
โ | General | $3,750.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $3,610.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $2,888.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $2,166.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
โ | General | $1,565.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $1,444.00 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
โ | General | $1,350.00 |
| Sanofi and Genzyme US Companies |
Travel and Lodging
In-kind items and services
|
DUPIXENT | General | $1,162.40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
OFEV | General | $479.95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
OFEV | General | $479.95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
OFEV | General | $292.88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
OFEV | General | $292.88 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
SYMBICORT | General | $191.72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
OFEV | General | $169.23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
OFEV | General | $169.23 |
| Inspire Medical Systems, Inc. |
Food and Beverage
In-kind items and services
|
INSPIRE | General | $154.03 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Travel and Lodging
In-kind items and services
|
โ | General | $140.00 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $129.56 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $128.50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $121.27 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
704 | 504 | $349.79 | $126.15 |
|
94729
Test to examine how well the lungs exchange gases
|
536 | 533 | $113.23 | $8.41 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
394 | 392 | $145.63 | $9.79 |
|
94726
Test to determine lung volumes using sensors
|
289 | 288 | $111.47 | $11.12 |
|
94727
Test to determine lung volumes using gas dilution or washout
|
242 | 240 | $115.08 | $11.61 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
190 | 190 | $447.63 | $165.08 |
|
94010
Test to measure expiratory airflow and volume
|
163 | 162 | $100.77 | $7.60 |
|
94060
Test to measure expiratory airflow and volume changes before and after medication administration
|
132 | 131 | $140.08 | $35.97 |
|
94727
Test to determine lung volumes using gas dilution or washout
|
130 | 129 | $104.77 | $41.16 |
|
94729
Test to examine how well the lungs exchange gases
|
127 | 126 | $103.39 | $51.01 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
103 | 100 | $267.48 | $89.25 |
|
99291
Critical care, first 30-74 minutes
|
81 | 52 | $663.89 | $208.19 |
|
94760
Test to measure oxygen level in blood using ear or finger device
|
69 | 69 | $100.00 | $2.66 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
67 | 63 | $373.88 | $175.75 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
66 | 40 | $255.91 | $116.49 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
48 | 47 | $416.67 | $165.84 |
|
94618
Test for exercise-induced lung stress
|
46 | 45 | $73.70 | $32.08 |
|
99309
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes
|
38 | 22 | $129.82 | $106.92 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
24 | 24 | $339.58 | $110.46 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
24 | 24 | $462.50 | $217.06 |
|
99306
Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more
|
24 | 22 | $229.17 | $180.95 |
|
99292
Critical care, each additional 30 minutes
|
21 | 18 | $310.71 | $104.87 |
|
99406
Smoking and tobacco use intensive counseling, 4-10 minutes
|
15 | 13 | $71.67 | $14.38 |
|
99239
Hospital discharge day management, more than 30 minutes
|
14 | 14 | $250.00 | $113.49 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 879 | 34,530 | $716,784.06 | 160 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 569 | 16,293 | $17,937.15 | 188 |
| Prednisone | Prednisone | 295 | 8,732 | $1,355.88 | 116 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 238 | 8,760 | $180,896.27 | 47 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 205 | 8,430 | $127,077.17 | 44 |
| Breo Ellipta | Fluticasone/Vilanterol | 180 | 6,960 | $91,068.30 | 42 |
| Montelukast Sodium | Montelukast Sodium | 151 | 10,318 | $1,864.52 | 49 |
| Incruse Ellipta | Umeclidinium Bromide | 151 | 5,370 | $59,885.58 | 36 |
| Dupixent Pen | Dupilumab | 150 | 4,172 | $603,981.40 | 23 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 146 | 5,820 | $18,521.69 | 45 |
| Spiriva Respimat | Tiotropium Bromide | 101 | 4,230 | $73,055.62 | 24 |
| Azithromycin | Azithromycin | 96 | 1,947 | $888.21 | 54 |
| Ventolin Hfa | Albuterol Sulfate | 87 | 2,527 | $6,061.46 | 33 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 80 | 3,957 | $23,342.34 | 30 |
| Symbicort | Budesonide/Formoterol Fumarate | 75 | 2,550 | $19,581.77 | 28 |
| Roflumilast | Roflumilast | 56 | 2,566 | $8,433.01 | 11 |
| Dulera | Mometasone/Formoterol | 43 | 1,380 | $15,673.58 | 12 |
| Advair Hfa | Fluticasone Propion/Salmeterol | 35 | 1,170 | $13,868.65 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 31 | 2,099 | $388.11 | 12 |
| Arnuity Ellipta | Fluticasone Furoate | 24 | 1,200 | $10,019.98 | โ |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 23 | 760 | $13,021.09 | โ |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | 1,290 | $4,420.99 | 12 |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 21 | 870 | $13,896.03 | โ |
| Zolpidem Tartrate | Zolpidem Tartrate | 18 | 780 | $63.53 | โ |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 18 | 555 | $912.83 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-01-29NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 208M00000X
Hospitalists are physicians whose primary professional focus is the general medical care of hospitalized patients. Their activities include patient care, teaching, research, and leadership related to Hospital Medicine. The term 'hospitalist' refers to physicians whose practice emphasizes providing care for hospitalized patients.
NUCC Taxonomy Code: 207RP1001X
An internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs.
NUCC Taxonomy Code: 390200000X
An individual who is enrolled in an organized health care education/training program leading to a degree, certification, registration, and/or licensure to provide health care.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20140722000236
NH
8729210828
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Incare Middleton, Pllc
565 Turnpike St, North Andover, MA 018455936
Phone: 9786892247
Incare Llc
140 Lincoln Ave, Haverhill, MA 018306700
Phone: 7816007599
Incare Lawrence, Pllc
565 Turnpike St, North Andover, MA 018455936
Phone: 9786892247
Incare Llc
166 Kinsley St, Nashua, NH 030603676
Phone: 9785194114
Incare Tufts Pllc
565 Turnpike St, North Andover, MA 018455936
Phone: 9786872247
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Hospitalist
Nurse Anesthetist, Certified Registered
Physician Assistant
Physician Assistant
Nurse Anesthetist, Certified Registered
Certified Registered Nurse Anesthetist
Nurse Practitioner
Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 70 EAST ST, METHUEN, MA 018444597 (Tel: 9786870151)
Registered at PO BOX 26311, BELFAST, ME 049152014 (Tel: 9786870151)
Internal Medicine (license number reported to NPPES: MA 248773)
NPI status registered as active in NPPES database
Registered at 87 MCGREGOR ST STE 1300, MANCHESTER, NH 031023765 (Tel: 6036456407)
Registered at 87 MCGREGOR ST STE 1300, MANCHESTER, NH 031023765 (Tel: 6036456407)
Recorded as PATRICK SCANLON, D.O.
Internal Medicine (license number reported to NPPES: NH 16426)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Methuen
- Dr. Brinda Rengaraju, MD
- Dr. Samuel Maghuyop, MD
- Dr. Sharda Kaul, MD
- Dr. Tricia Allman, MD
- Dr. Chih Yeh, MD
- Dr. Hussein Al Jobori, MD
Mailing Address
Po Box 26311
Belfast, ME 049152014
Phone: 9786870151